iFabric Corp. Announces US EPA Registration of TWO New Cutting-Edge Antimicrobial Technologies
- iFabric Corp. achieves US EPA registrations for bioFRESH and PROTX2 S antimicrobial technologies.
- The registration signifies the company's dedication to providing groundbreaking solutions for customers.
- bioFRESH offers sustainable antimicrobial protection, while PROTX2 S expands the product range.
- President Giancarlo Beevis emphasizes the environmental benefits and increased options for customers.
- iFabric Corp. remains at the forefront of antimicrobial innovation, empowering various industries.
- None.
MARKHAM, ON / ACCESSWIRE / April 23, 2024 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF), a leading provider of innovative apparel and textile technologies, announces that its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has received United States Environmental Agency ("EPA") registrations for two of its latest antimicrobial textile innovations. This significant milestone underscores iFabric's commitment to providing groundbreaking solutions to meet the evolving needs of our customers and addressing emerging challenges in the field of antimicrobial protection.
Among the technologies, granted registration is bioFRESH, our revolutionary bio-based antimicrobial technology. "As the sustainability landscape continues to evolve, bioFRESH offers a large-scale opportunity to advance environmental stewardship while maintaining superior performance in antimicrobial protection," stated Giancarlo Beevis, President and Chief Executive Officer of IFTNA. "bioFRESH provides an effective and eco-friendly solution for a wide range of applications, from textiles to healthcare facilities and beyond," continued Mr. Beevis.
"In addition to bioFRESH, I am excited to introduce PROTX2 S, our new hydrothermal mineral-based antimicrobial technology. This innovative addition expands our product portfolio, offering customers a greater selection of antimicrobial solutions to meet their specific needs," continued Mr. Beevis.
"The US EPA registrations of our latest antimicrobial technologies are a testament to our ongoing commitment to innovation and excellence. We are proud to offer bioFRESH and PROTX2 S to our customers, which will provide them with even more options to protect their environments. With these advancements, IFTNA remains at the forefront of antimicrobial innovation, empowering customers across multiple industries to offer products that are effective against microbial threats," concluded Mr. Beevis.
About iFabric Corp:
Headquartered in Markham, Ontario, iFabric, www.ifabriccorp.com, is listed on the TSX and, currently has 30.3 million shares issued and outstanding. Its two strategic divisions offer a variety of products and services through wholly-owned subsidiaries, namely, Intelligent Fabric Technologies (North America) Inc. ("IFTNA") and Coconut Grove Pads Inc. ("Coconut Grove").
IFTNA is focused on development and sale of high-performance sports apparel, medical protective apparel, consumer protective apparel, and proprietary treatments that provide "intelligent" properties to fabrics, foams, plastics, and numerous other surfaces, thereby improving the safety and well-being of the user. Such intelligent properties include antiviral and antibacterial characteristics, water-repellence and UV protection, among others.
Coconut Grove, operating as Coconut Grove Intimates, is a designer, manufacturer, distributor, licensor and licensee of ladies' intimate apparel products and accessories.
FORWARD LOOKING STATEMENTS
Forward-looking statements provide an opinion as to the effect of certain events and trends on the business. Certain statements contained in this news release constitute forward looking statements. The use of any words such as "anticipate", "continue", "plans", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: the extent and impact of health pandemic outbreaks on our business; general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; the actual results of the Company's future operations; competition; changes in legislation affecting the Company; the ability to obtain and maintain required permits and approvals, the timing and availability of external financing on acceptable terms; lack of qualified, skilled labour or loss of key individuals.
A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company's annual information form dated April 1, 2024 and other filings with the Canadian securities regulators available under the Company's profile on SEDAR+ at www.sedarplus.ca. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.
Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made. Readers are cautioned not to place undue reliance on these statements as the Company's actual results, performance, or achievements may differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements if known or unknown risks, uncertainties or other factors affect the Company's business, or if the Company's estimates or assumptions prove inaccurate. Therefore, the Company cannot provide any assurance that forward-looking statements will materialize. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Any financial outlook or future oriented financial information in this news release, as defined by applicable securities legislation, has been approved by management of iFabric. Such financial outlook or future oriented financial information is provided for the purpose of providing information about management's reasonable expectations as to the anticipated results of its proposed business activities. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or any other reason except as required by applicable securities laws.
FOR FURTHER INFORMATION please contact:
Hylton Karon, President and CEO
Tel: 905.752.0566 ext 201
Email: hyltonk@ifabriccorp.com
Hilton Price, CFO
Tel: 647.465.6161
Email: hilton.price@rogers.com
Website: www.ifabriccorp.com
Neither the TSX Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this press release.
SOURCE: iFabric Corp
View the original press release on accesswire.com
FAQ
What new technologies did iFabric Corp. announce the US EPA registration for?
What is bioFRESH?
What is PROTX2 S?
Who is the President and CEO of Intelligent Fabric Technologies (North America) Inc.?
What benefits does bioFRESH offer?
What does the US EPA registration of the antimicrobial technologies signify?
